Genetic evidence has implicated several genes as being critical for heart development.
expression at early stage HH4, as visualized by whole-mount in situ hybridization (Fig.   1H ). The specificity of these results was confirmed upon comparison with the ubiquitous fluorescence observed in the pCCAGs-AFP electroporated control embryo ( Figure 1E ).
Isolation of heart precursor cells (HPC) and RNA collection
To identify transcripts differentially expressed during early cardiac development in the cCer2.5-EGFP positive population, we microdissected this region at stage HH4, and dissociated the tissue into a single cell suspension. The EGFP positive cells from the HFR pool were sorted using FACS. The negative control population was derived from the posterior part of the primitive streak (PPPS), a non cardiac region, to minimize the risk of losing unknown cardiac genes that are expressed in the mesendoderm tissues.
The subtractive hybridization scheme is outlined in Figure 2A .
Prior to sorting, we evaluated whether the cells from the targeted areas were typical embryonic chick cells (Fig. 2B) . Indeed, the R3 region contains cells with a level of granularity similar to that seen in the control embryonic chick cells (data not shown).
This approach yielded successful separation of the two different populations (EGFP negative versus EGFP positive cells; Fig. 2C ). In the R8 gated region, approximately 6% of the total number of cells was EGFP-positive. To assess purity and viability of the HPC a preliminary sorting process of approximately 100 cells was conducted. This initial FACS analysis of the sorted EGFP-labeled cells indicated a cell viability and purity of 99% (data not shown), confirming that no EGFP negative cells had been collected and that the mechanical stress exerted on the cells during FACS had no effect on their viability. The complete cell suspension was then sorted resulting in the isolation of approximately 4000 EGFP positive cells. These cells were collected directly for RNA extraction. Despite the low number of cells a high quality RNA sample was obtained.
Due to the limiting amount of total RNA extracted from the isolated cells, a two round linear amplification method was employed to obtain the required amount of fragmented biotinylated cRNA for hybridization to the GeneChip microarray.
The cRNA pool obtained from the first cycle of amplification was analyzed for the relative presence/absence of known markers in order to test the feasibility of the differential screening (Fig. 2D ). We used cCer as a marker of early endomesoderm, cNodal as a PS marker and cNot1 as a HN marker. The EGFP positive population only expressed cCer. The PPPS population was positive for cNodal and cCer. cNot1 expression was absent in both EGFP positive and PPPS populations. The whole embryo was positive for all the markers. All cell populations expressed GAPDH that was used as a reference gene.
Identification and functional network analysis of differentially expressed genes
in heart precursor cells
The Affimetrix GeneChip® Chicken Genome array was used to compare the cRNA pools of EGFP positive and PPPS cell populations. The resultant data were classified and organized, using DAVID and IPA tools.
The differential screening resulted in the detection of 777 genes that are differentially expressed with a fold change greater than 2. The microarray data used in this analysis has been submitted to NCBI GEO database under accession number GSE23389 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23389).
Gene ontology analysis was carried out on significantly regulated transcripts using DAVID (http://david.abcc.ncifcrf.gov/). The transcripts were organized ( Figure 3A) into an upregulated population that contains a total of 437genes, which includes 301 uncharacterized (119 unknown genes and 182 annotated genes), and 136 characterized (of which 38 have GeneRIF). This gene expression screening also revealed 340 downregulated genes in the HPC enriched cell population, of these 205 were uncharacterized (80 unknown genes and 125 annotated genes), and 135 characterized (of which 44 have GeneRIF).
The detailed analysis of the obtained list of characterized upregulated genes in the EGFP positive population showed that several were previously associated with HPC populations, such as Fgf8, TNNT2, NRP1, Isl-1 and Wnt11 (Fig. 3B ).
We used Ingenuity Pathway Analysis (Ingenuity® Systems, www.ingenuity.com) algorithms and database to dynamically generate significant biological networks from the gene expression data sets. From the analysis of the pool of upregulated characterized genes resulted a list of associated network functions, being Cellular Movement, Cardiovascular System Development and Function, Cellular Development the network with highest score (45; Table1).
2.4. Validation of the differentially expressed candidate genes in the heart precursor cells From the list of upregulated uncharacterized genes, we selected a number of genes for expression pattern characterization. The selection was based on their fold change and predicted function.
We named them CHEP33 (which stands for Chick Heart Progenitor #33), CHEP36, CHEP40 and CHEP18. CHEP36 was also found in a previously screening for Anterior
Visceral Endoderm genes performed in our lab, and denominated as ADTK1 (Anterior Distal Tyrosine Kinase 1; Gonçalves et al, 2011) . For that reason this gene will be renamed as cAdtk1 in this manuscript.
The cAdtk1 gene (GenBank accession no. CR405754.1) is 6,8 fold upregulated in the HFR when compared with the posterior part of the Primitive streak. Whole-mount in situ hybridization of cAdtk1 ( Fig. 4A-H) showed that it is expressed as early as stage HH4 in the anterior mesendoderm ( Fig. 4A ) with an expression pattern similar to that of cCer ( Fig. 1H) . At stage HH5-6 expression is restricted to a mesodermal area on either side of the embryo overlapping the heart fields and in a more medial ectodermal region on both sides of the head process (Fig. 4B , C and C'). At stage HH7-8 expression is seen in both in the lateral plate mesoderm and in the proamnion (extra-embryonic ectoderm and extra-embryonic endoderm) (Fig. 4D, D ', D'' and E) . By stage HH9, cAdtk1 seems to be expressed in the wall of sinus venosus ( Fig. 4F and F' ). At stage HH10, expression appears to be restricted to the heart tube region and and lateral plate mesoderm ( Fig. 4G ). At later stages by HH14 expression persists in the lateral plate mesoderm and amnion, and a new expression domain can be seen in the tail bud mesoderm ( Fig. 4H and data not shown).
CHEP33 (GenBank accession no. XM_421599) was obtained in the differential screening with a +4,4 fold change, and encodes for a putative protein of 239 amino acids. The predicted amino acid sequence of chick CHEP33 is identical 90,8% and 90,5% to its human and mouse orthologs respectively and contains a predicted Zincfinger motif. Expression of CHEP33 was initially detected at stage HH4 by wholemount in situ hybridization in bilateral prospective heart fields on the left and right sides of the embryo (Fig. 4I) . At stage HH5 CHEP33 transcripts are detected in a large mesodermal area (Fig. 4J, J' ) and by stage HH7-8 expression can be observed in the lateral plate mesoderm where heart precursors lay, and in the forming somites (Fig. 4K) .
By stage HH9, expression is visible in the forming heart tube and in the somites (Fig.   4L ). At stage HH11-12, the heart is intensely labeled, as well as the somites and staining in the head and lateral plate mesoderm becomes evident (Fig. 4M-N) .
Histological sections shown that CHEP33 is present specifically in the myocardium, pharyngeal endoderm, neural tube, derma-myotome and somatic lateral plate mesoderm.
Later in development CHEP33 is strongly expressed in the heart (Fig. 4O ).
CHEP40 gene (GenBank accession no. XM_418631.2) was detected in the screening with a +5,0 fold change, and encodes for a putative protein of 893 a.a. The predicted amino acid sequence of chick CHEP40 has several homologues in other species, and contains a putative transmembrane domain in the medial portion of the protein. It also contains conserved domains predicted to be involved in cell adhesion, like the desintegrin and Protocadherin domains. Whole-mount in situ hybridization showed that by stage HH4+ CHEP40 transcripts are detected in the HFR mesoderm (Fig. 5A , A' and A''). However, they are also present in the three germ layers of the area pellucida of the embryo, but absent in the primitive streak. At this stage of development, transcripts of CHEP40 are also detected in the posterior part of the area opaca. At stage HH6, CHEP40 is highly expressed in the area pellucida except for the head process, Hensen's node and primitive streak. Some staining is also observed on the extraembryonic part of the embryo (Fig. 5B) . Later in development, at HH8 CHEP40 transcripts are present in the heart primordium ( Fig. 5C ) and at stages HH10 to 14 CHEP40 transcripts were detected in the heart endocardium, intraembryonic vasculature, anterior intestinal portal and neural fold tip ( 
Discussion
The heart is the first organ to become functional in the vertebrate embryo. It develops from two bilateral heart fields located in the anterior lateral mesoderm of the early embryo, which are formed during gastrulation. A vast array of genes and signaling pathways have been reported to be crucial in all steps of cardiogenesis, from migration of primitive-streak progenitor cells, formation of primary and secondary heart fields, fusion of cardiac crescent cells, cardiac looping, to later morphogenetic mechanisms.
Developmental signaling pathways are required to act in combination with tissuespecific transcriptional cofactors to elicit inductive responses. The spatial and temporal orchestration of these processes implies a complex program of genetic control, exerted in large part through precisely controlled processes of cell-cell signaling and regulators of gene expression.
We generated a cCer2.5-EGFP construct that effectively produces specific expression in cells leaving the PS at HH3+ and later populate the heart tube.
To confirm the identity of the isolated cell population, a RT-PCR analysis was performed. Known cardiac genes such as NKX2.5 and GATA4 were not used in this analysis because they are only expressed later, by stage HH5 (Abu-Issa and Kirby, 2007; Warkman et al., 2008) . For that reason we used cCer as a marker of early endomesoderm, cNodal as a PS marker, and cNot1 as an HN marker. Our results were in agreement with the expected since the selected EGFP+ cell population expresses cCer and doesn't express cNodal, suggesting that we have isolated an enriched population of endomesoderm containing heart precursor cells. The presence of cCer transcripts in the PPPS region can be explained since at stage HH4 cCer expressing cells are leaving the primitive streak toward the cardiogenic mesoderm, and the dissected posterior region contains some of these cells (Fig. 1H) .
A successful combination of methods was employed, resulting in the isolation of 777 independent transcripts potentially implicated in early heart development at stage HH4.
These results were catalogued using DAVID ( Figure 3A ). In our study, reference genes as Actin and GAPDH showed no fold change, since they are ubiquitously expressed in all eukaryotic cells (Fig. 3B ). This also indicates that the EGFP positive population and the negative control have a similar number of cells. We defined as upregulated genes, those found differentially expressed and increased in the EGFP-positive population when compared with the control population. From the pool of upregulated genes, several known cardiac genes were found to be present, some of which with great relevance during early heart development. Both NRP1 and Wnt11 genes were strongly expressed in the EGFP-positive cell population and have been previously implicated in HPC mechanisms. NRP1 has been described to be a pro-angiogenic receptor (Ball et al., 2010) , and that in order to promote cardiomyogenesis, the Wnt canonical pathway must be blocked by Wnt inhibitors, such as Wnt11 (Marvin et al., 2001; Maye et al., 2004) . Multipotent cardiovascular progenitor cells, which express Isl1 together with Nkx2.5
and Flk-1, give rise to cardiomyocytes, smooth muscle cells, and endothelial cells, representing all three major cell lineages of the heart (Moretti et al., 2006) . Flk-1 and Isl1 expressions were found to be upregulated in the EGFP positive population. Another gene found to be enriched in this cell population was TNNT2, which is known to be present in the embryonic heart of the chick and is responsible for binding tropomyosin to regulate calcium binding and contractility of heart muscle (Druyan et al., 2007) . Fgf8 is one of the earliest genes known to regulate myocardial progenitor cells, that when reduced in expression leads to abnormal heart development. Though WISH studies at HH4 show its expression occurs in the cranial part of the PS (Dathe et al., 2002) , we also found it to be enriched in the HPC when compared to our control cell population. Therefore, the interpretation of some results might not be immediate, as several differentially expressed genes are known to be involved in vasculogenic and angiogenic processes (Flk1, . Additionally, multiple genes associated with hemangioblast fate, including Flk-1 and Scl were detected. This led us to suppose that along with the cardiac precursor cells, hemangioblasts were also isolated. The hemangioblast was proposed a long time ago to be the common precursor for endothelial and hematopoietic cells, and the hemangioblast cells of the lateral plate mesoderm can give rise to both the angioblasts of the vascular system and the pluripotential hematopoietic stem cells of the blood and lymphoid systems. The primitive endothelial and hematopoietic lineages are believed to derive from mesodermal cells that have migrated from the PS to form the blood islands in the extraembryonic yolk sac, being Flk-1 and Scl two critical molecules involved in this process (Murray, 1932; Ema et al., 2003) . It has also been reported that the region in the mesoderm posteriorly adjacent to the cardiogenic region is responsible for the emergence of the blood precursors. We assume that the presence of both heart and hemangioblast precursor cells in our differential screening can be explained by the use of 2.5cCer as a reporter. This transgene also drives the expression of EGFP in the anteriormost hemangioblast population (Fig. 1F and G) , which is contiguous to the cardiac precursor cells region. However the isolation of both cell precursors doesn't invalidate our aim to study cardiogenesis. In a study performed in zebrafish, a close genetic link between anterior hemangioblast and cardiac precursors was identified which supports the notion that the anterior hemangioblast population is an evolutionary ancestor of the second heart field (Peterkin et al., 2009). Moreover, cardiomyocytes have been obtained from ES cell derivatives expressing the hemangioblast marker, VEGF receptor, Flk-1, which is consistent with the idea of common genetic programme (Kattman et al., 2006) . It is known that the cardiogenic process at such early stages needs BMP signaling from the anterior endoderm (Schultheiss et al., 1997) , to induce a field with cardiogenic competence, and it is also known that in this region Wnt inhibition is necessary to promote cardiomyogenesis (Schneider and Mercola, 2001; Marvin et al., 2001 ). As we mentioned before, Wnt11, an inhibitor of the Wnt canonical pathway (Maye et al., 2004) , was found to be more expressed in sorted cells, which was to be expected since it should be present to promote cardiomyogenesis. However, Bmp2
and Bmp4 were not found to be enriched in the HPC. This is probably due to the fact that the region selected as negative control also expresses these genes at a similar expression level (Marvin et al., 2001; Brand, 2003) .
IPA tool was used to evaluate if the characterized genes found enriched in the EGFP positive population, were together due to random change. A list of associated network functions was produced being Cellular Movement, Cardiovascular System Development and Function, Cellular Development the one with highest score (45; Table1), meaning that there is a 1 in 2250 chance that the Focus Genes are together due to random chance.
The enrichment of cardiac specific genes in the EGFP population, together with the functional in silico characterization of the differentially regulated transcripts, strengthens the possibility that heart precursor cell isolation was accomplished.
Following categorization of the genes differentially expressed in the HPC at stage HH4, we focused our study on the 301 upregulated uncharacterized transcripts. Aware of the possible existence of false positives among these novel genes due to the absence of replicates for our arrays, we performed whole-mount in situ hybridizations to determine if they fitted HPC expression. Four genes were chosen for further characterization:
CHEP33 a novel gene with a putative zinc finger binding domain; cAdtk1 containing a predicted dual-specificity Ser/Thr/Tyr kinase catalytic domain; CHEP40 a novel gene possibly involved in cell adhesion and CHEP18 that belongs to the VHS ENTH-ANTH superfamily. The whole-mount in situ hybridizations performed in this study showed that the expression patterns of the novel genes overlap with the HPC region. However, expression of CHEP18 at stage HH4 is absent in the HFR. This could be due to a weak expression level that would not be detected by whole-mount in situ hybridization. Or, as there is a narrow window of time between stages HH4 and HH5, it is possible that some embryos collected for the screening could have been at an early HH5 stage, and already expressing CHEP18 in the HFR. As for the expression of CHEP40 at stage HH4, expression can be observed almost all over the area pellucida, being however weaker in the posterior part of the embryo than in the HFR. At first this fact seems to invalidate the experimental approach used as the basis of this study, however by analyzing the expression pattern carefully, it can be seen that both the posterior part of the embryo and the primitive streak are less stained than the HFR. As this screening is a differential one, one cell population versus another, the plausible explanation of these results is that CHEP40 is expressed 5 times more in the HFR mesoderm than in the posterior part of the primitive streak. The posterior part of the area opaca at HH4 is usually associated to vascular cell populations, which can explain CHEP40 expression at HH10 in the intraembryonic vessels. At early cardiac formation stages expression was found in the heart for CHEP33, CHEP18 and CHEP40. cAdtk1 is present in HFR during pre-heart tube stages, being as well present in structures adjacent to the heart after its formation.
This gene, as previously described in mouse embryos, is also absent from the heart tube at early cardiac stages (Imuta et al., 2009) . Nevertheless it has been described to be strongly expressed in the heart of adult mice. In the mouse, at E6.5 Pkdcc (cAdtk1 ortholog) is expressed in the anterior viseral endoderm and anterior PS, whereas in the chick at HH4 there is no expression in the PS. In the chick at HH5 cAdtk1 is expressed in the HFR mesoderm and in the neural plate ectoderm, whereas no ectodermal expression is seen in the mouse at E7.5. WISH studies of the four selected clones allowed us to corroborate the hypothesis that the cCer positive population expresses cardiogenic genes. This was proven by the detection in the heart, later in development, of transcripts of these studied genes. Furthermore, the expression of the new clones in the mesendoderm at stage HH4, validates the differential screening which involved the RNA isolated from these cells at the same stage.
In conclusion, we have identified a large set of novel genes that are differentially expressed in the H/HPC precursor lineages. By developing a procedure to isolate the heart precursor cells using the cer2.5-EGFP construct, we were able to specifically separate a population of H/HPC expressing already known cardiac markers, and a long list of still uncharacterized genes. From those, we demonstrated by WISH that a number of these in silico-identified transcripts are in fact expressed in these cell populations and potentially required for heart formation. More importantly, our study unveiled a large number of uncharacterized genes that can now be used by the scientific community for further developmental studies. , 2006) . Only genes called Present in at least one of the two arrays in this study were kept for downstream analysis (17575 genes). All genes compared were considered to be differentially expressed if the 90% lower confidence bound of the fold change between experiment and baseline was above 2. The lower confidence bound criterion means that we can be 90% confident that the fold change is a value between the lower confidence bound and a variable upper confidence bound. It has been shown that the lower confidence bound is a conservative estimate of the fold change, and therefore more reliable as a ranking statistic for changes in gene expression (Li and Wong, 2001 ).
Gene list analysis using bioinformatic resources (DAVID and Ingenuity
Pathway Analysis) Genes identified by Affymetrix and with a fold change calculated greater than 2 were used for network and gene ontology analyses.
Gene accession numbers were uploaded into DAVID (http://david.abcc.ncifcrf.gov/) (Huang et al., 2009; Dennis et al., 2003) to filter the redundancy and categorize according to the degree of annotation. The set of up and downregulatedgenes was subdivided into characterized and uncharacterized. The uncharacterized genes include genes that have an ID in Entrez or Ensemble databases (annotated), and genes that do not (unknown). The characterized genes are annotated genes that have been published (PUBMED ID), some of these with functional information (GeneRIF).
Gene accession numbers were imported into the Ingenuity Pathway Analysis version 8.0 (IPA) software (Ingenuity Systems ®, Mountain View, CA, USA), and are the starting point for generating biological networks. IPA then computed a score for each network according to the fit of the user's set of significant genes. A score of 2 indicated a 1 in 100 chance that the focus genes were together in a network because of random chance. Since the size of the created network could potentially be enormous, the IPA software limited the number of molecules in the network to 35, leaving only the most important ones based on the number of connections for each focus gene (focus genes = a subset of uploaded significant genes having direct interactions with other genes in the database) to other significant genes. Networks are scored based on the number of focus molecules in the network, its size, the total number of focus molecules analyzed, and the total number of molecules in the knowledge database that could potentially be included in the networks.
Clones selection and whole-mount in situ hybridization
Chicken EST's for the selected clones were obtained from the BBSRC chick EST database (Hubbard et al., 2004) . Clones used were ChEST884h13 for cAdtk1 (seq. identifier 603865952F1), ChEST514i19 for CHEP33 (seq. identifier 603542577F1), ChEST739g15 for CHEP40 (seq. identifier 603784860F1) and ChEST746d11 for CHEP18 (seq. identifier 603787942F1).
The clones were sequenced using T7 and T3 primers and whole-mount in situ hybridization was performed as previously described (Wilknson, 1993) . DIG labeled RNA probes were generated by digesting plasmids with Not I, and transcribing with T7 RNA polymerase. EGFP fluorescence is observed specifically in the future extraembryonic mesoderm and heart precursor cells (arrow in D'). (F-G): Expression is localised in the extraembryonic mesoderm and cardiogenic region (F,F'), and later in the heart and blood islands (G). In G', fluorescence is seen in the heart (arrow) and in a few cells of the pharynx. In G'' labelled cells are localised both in the endothelium and inside the hematopoietic region of the blood islands (arrows). (H): cCer transcripts were detected by whole-mount in situ hybridization in the anterior mesendoderm.
(ames anterior mesendoderm, hf heart fields, mes mesoderm, hp heart precursors, ht heart tube, pcar pre cardiac region, endo endothelium, ht heart, pha pharynx, bi blood islands) (ames anterior mesendoderm, hf heart fields, np neural plate, nfp neural fold patches, mes mesoderm, lpm lateral plate mesoderm, pa pro-amnion, hp heart primordium, ht heart, wsv wall of sinus venosus, tbm tail bud mesoderm, s somites, nt neural tube, phe pharyngeal endoderm, myo myocardium, dmyo derma-myotome, sm somatic lateral plate mesoderm).
Figure 5 In vivo validation of the differential screening (CHEP40 and CHEP18).
Whole-mount in situ hybridization and paraffin sectioning for CHEP40 (A-F) and CHEP18 (G-M), in the chick embryo: (A) CHEP40 is present with greater intensity in the anterior part of the area pellucida, except for the primitive streak and Hensen's node, and also in the posterior part of the area opaca; (A'and A'') the expression is visible in the three embryonic layers, endoderm, mesoderm and ectoderm; (B) staining is observed heavily in the entire area pellucida except for the primitive streak, Hensen's node and head process; (C) at early somite stage CHEP40 expression is seen in the heart primordium; (D-F and D'-E'') after heart tube formation expression is seen in the heart endocardium (D', E' and E''), intraembryonic vasculature (D-F and E'), endoderm adjacent to the sinu-atrial region (D') and neural fold tip (D' and E'); (G) CHEP18 expression is present in the posterior and lateral part of the area opaca; (H-K and H'-J'') staining can be observed in the mesodermal layer on either side of Hensen's node (PS Primitive Streak; ec ectoderm; mes mesoderm; en endoderm; HN Hensen´s node HP head process; hp heart primordium; ht heart; iev intraembryonic vasculature; nf neural fold; He Heart endocardium; eem extraembryonic mesoderm; eev extraembryonic vasculature; hm head mesenchyme; sm somatic lateral plate mesoderm; sp splanchnic lateral plate mesoderm; mv microvessels; pCV posterior cardinal veins;) Tables   Table 1 
